Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) affects approximately 1% of the general population. It is a chronic, disabling, multi-system disease for which there is no effective treatment. This is probably related to the limited knowledge about its origin. Here, we summarized the c...
Saved in:
Main Authors: | Manuel Ruiz-Pablos, Bruno Paiva, Rosario Montero-Mateo, Nicolas Garcia, Aintzane Zabaleta |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/40b36b3f5a574fb7adff4134fe44b6a4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
by: Iñigo Murga, et al.
Published: (2021) -
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Klaus J. Wirth, et al.
Published: (2021) -
Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients
by: Nguyen,T., et al.
Published: (2016) -
Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Helen Brownlie, et al.
Published: (2021) -
Associations Between Psychological and Immunological Variables in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review
by: Emilie F. W. Raanes, et al.
Published: (2021)